back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-05-17 10:18 Tx date 2024-05-16 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,600
+10,000 vol $0.46 each |
40,000 | |
| Filed 2024-05-17 10:18 Tx date 2024-05-16 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,700
+10,000 vol $0.47 each |
30,000 | |
| Filed 2023-09-12 10:44 Tx date 2023-09-08 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,000
+14,000 vol $0.50 each |
20,000 | |
| Filed 2023-09-12 10:43 Tx date 2023-09-08 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,020
+2,000 vol $0.51 each |
6,000 | |
| Filed 2023-09-12 10:43 Tx date 2023-09-08 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,960
+4,000 vol $0.49 each |
4,000 | |
| Filed 2023-09-12 10:42 Tx date 2023-09-01 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-12 10:42 Tx date 2023-09-07 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,000
+1,100,000 vol $0.41 each |
1,100,000 | |
| Filed 2023-09-12 10:42 Tx date 2023-09-01 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-12 10:41 Tx date 2023-09-01 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-12 10:41 Tx date 2023-09-01 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-12 10:41 Tx date 2023-09-07 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$29,520
+72,000 vol $0.41 each |
||
| Filed 2023-09-12 10:40 Tx date 2023-09-01 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-12 10:40 Tx date 2023-09-07 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$29,520
+72,000 vol $0.41 each |
||
| Filed 2023-09-12 10:39 Tx date 2023-09-01 |
$MSCL
Satellos Bioscience Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-28 17:30 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$259,349
+178,862 vol $1.45 each |
827,463 | |
| Filed 2022-03-09 14:59 Tx date 2022-03-09 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+5,000 vol $1.80 each |
15,300 | |
| Filed 2021-11-01 16:29 Tx date 2021-11-01 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,982
+4,000 vol $2.75 each |
10,300 | |
| Filed 2021-09-24 17:40 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$213,749
+68,073 vol $3.14 each |
648,601 | |
| Filed 2021-01-07 09:34 Tx date 2021-01-06 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,220
+1,000 vol $5.22 each |
6,300 | |
| Filed 2020-11-05 09:14 Tx date 2020-11-03 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$155,998
+30,528 vol $5.11 each |
580,528 | |
| Filed 2019-11-11 16:26 Tx date 2019-11-08 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$195,000
+150,000 vol $1.30 each |
550,000 | |
| Filed 2019-02-19 Tx date 2019-02-14 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+200,000 vol $1.00 each |
400,000 | |
| Filed 2017-09-26 Tx date 2017-09-21 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,749
+75,000 vol $2.01 each |
200,000 | |
| Filed 2017-03-13 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,300 | ||
| Filed 2017-03-13 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
| Filed 2016-04-04 Tx date 2016-03-31 |
$APS
Aptose Biosciences Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$76,400
+20,000 vol $3.82 each |
76,416 | |
| Filed 2015-06-11 Tx date 2015-06-10 |
$APS
Aptose Biosciences Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$139,200
+20,000 vol $6.96 each |
56,416 | |
| Filed 2015-06-11 Tx date 2015-06-10 |
$APS
Aptose Biosciences Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
36,416 | ||
| Filed 2015-06-11 Tx date 2015-06-10 |
$APS
Aptose Biosciences Inc. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
36 |